An Australian Charity Is Giving Away MDMA And Magic Mushrooms For Free
Dmarge, May 19, 2023
The blossoming world of psychedelic therapy could change the face of mental health treatment. With trials returning continually stronger evidence for the benefits of psychedelic therapy in treating a number of conditions, one Australian charity has announced that it will provide the drugs free of cost in the hope of rolling-out new treatments quicker and more equitably.
Optimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical Market
Australian Associated Press, May 17, 2023
Upon completion of validated regulatory and clinical documentation, the GMP extracted product will be exported to Australia in preparation for the country’s Authorised Prescriber Scheme on July 1, 2023.
Psychedelic assisted therapy
IT'S ALL TRUE? Podcast, May 1, 2023
Chezzi and Grant Denyer from It’s All True Podcast interviewed Co-Founder and Executive Director Tania de Jong AM to explain the the positive benefits of psychedelic assisted therapies and the TGA’s decision to permit psychedelic treatment.
The Future Of Psychedelic Assisted Therapies with Tania De Jong (EP#189)
SuperFeast Podcast, April 24, 2023
Tania de Jong AM from Mind Medicine Australia joins Mason for another inspiring and informative conversation on the topic of psychedelic-assisted therapies.
I Travelled 16,632 Kilometres To Improve My Mental Health: A Psilocybin Story
DMarge, April 11, 2023
The psilocybin craze has kicked into overdrive thanks to the likes of Netflix’s How to Change Your Mind and podcasters like Tim Ferriss spruiking its endless benefits. We wanted to see it with our own eyes, so we travelled to Amsterdam, the drug capital of the world, to experience psilocybin therapy or psychedelic insight for ourselves.
Mind Medicine Australia funds studies investigating psilocybin and MDMA
PsychedelicHealth.co.uk, March 23, 2023
Mind Medicine Australia has provided funding for two studies that will be investigating the use of psilocybin and MDMA. Both studies will be carried out by the ANU School of Medicine and Psychology and led by Professor Paul Fitzgerald, Associate Professor Bernadette Fitzgibbon and Dr Neil Bailey.
Psychedelics: the future of mental health treatments?
Herald Sun, March 5, 2023
Australia has become the first country in the world to legalise the therapeutic use of MDMA and psilocybin.
Historic Supply Agreement Signed
Global News Wire, March 1, 2023
Mind Medicine Australia enters into historic supply agreement with Canadian end-to-end GMP manufacturer, Optimi Health. Read the full media release from Optimi Health.
Psilocybin promotor’s response
ABC, February 27, 2023
Mind Medicine Australia share their thoughts on the recent approval of psychedelic compounds for treatment-resistant depression and PTSD.
The Recent TGA Rescheduling of Psilocybin and MDMA Will Help Solve Our Accelerating Mental Health Epidemic
The Social Blueprint, February 17, 2023
Enter Mind Medicine Australia, a registered charity and Australia’s leading not-for-profit organization working on the use of medicinal psilocybin and MDMA-assisted therapies to treat a range of mental illnesses and expand the treatment options available to medical practitioners and their patients in clinical environments.
MDMA and psilocybin treatments to be offered in the Hunter for PTSD and depression
Newcastle Herald, February 17, 2023
MDMA and psilocybin treatments to be offered in the Hunter for PTSD and depression through psychiatrist Dr Stuart Saker, as Vietnam veteran and PTSD sufferer Roger Priest shares his story.
The changing legal landscape of psychedelics in Australia
Lawyers Weekly, February 16, 2023
Peter Hunt AM has been a leading advocate for change to the legal classification of psychedelic medicines in Australia, with the hope that it will revolutionise mental healthcare and outcomes for those across Australia.
On this episode of The Lawyers Weekly Show, host Jess Feyder speaks with Mr Hunt, co-founder of the organisation Mind Medicine Australia, about psychedelic medicines and the changing legalities in Australia.
Australia Becomes First Nation To Allow Medical Use of Magic Mushrooms and MDMA
Longevity Live, February 15, 2023
In recent years, the opinion of psychedelic drugs has shifted, especially with growing research suggesting their potential as health-improving medicines. Now, in a groundbreaking decision, Australia recently announced that as of July 1st, it would legalize the use of psilocybin and MDMA – for health conditions of course.
From Magic Mushrooms to Meds
Australian Financial Review, February 12, 2023
The TGA’s approval of the psychedelics MDMA and psilocybin as medicines has generated anxiety about a lack of regulation, but also optimism that they might succeed where other treatments fail.
Australia just legalised MDMA to treat mental health. Could Europe do the same?
Euro News, February 10, 2023
This week, Australia has announced it will officially recognise psychedelic drugs MDMA and psilocybin as medical treatments for conditions including PTSD, depression, alcoholism and eating disorders.
The news has come as a bit of a surprise; Australia’s Therapeutic Goods Administration (TGA) overruled the use of psychedelic drugs as recently as December 2021.
What went right this week: psychedelics for mental health, plus more
Positive News, February 9, 2023
Australia has become the first country to recognise psychedelics as medicines for treating depression and post-traumatic stress disorder (PTSD).
The landmark decision by Australia’s Therapeutic Goods Administration means that MDMA (commonly known as ecstasy) and psilocybin – the active compound in ‘magic’ mushrooms – will finally be available on prescription after decades of demonisation.
Magic Cure Or An Expensive Trip? Psychedelics Explained
The Quicky - Mamamia Podcasts, February 9, 2023
In today’s episode of The Quicky, Tania de Jong and Vanessa Bortolin sit down to discuss psychedelic treatment for mental illness, the recently announced TGA decision, and Vanessa’s tragic story.
Australia Becomes The First Country To Approve MDMA And Psilocybin For Medical Use
EDM Tunes, February 8, 2023
Hooray for Australia! Today, Australia became the first country to approve the use of two psychedelics for medical purposes. The psychedelics in question are MDMA, better known by its street name ecstasy, and psilocybin found mainly in mushrooms. This marks a historical move, as Australia becomes the first country to approve both substances for medical use. The reactions to the legalization of these psychedelic substances have been mixed.
Psychedelics May Be Part of U.S. Medicine Sooner Than You Think
Time, February 8, 2023
It came as a surprise to many when, on Feb. 3, Australian regulators announced that medicines containing the psychedelic substances MDMA and psilocybin can soon be used there to treat post-traumatic stress disorder (PTSD) and treatment-resistant depression, respectively. That decision makes Australia the first country in the world to formally recognize the therapeutic use of psychedelics.
Other countries, including the U.S., may be headed toward a similar outcome, some experts say.
TGA Approves Psilocybin, MDMA for Mental Health Treatment
Man of Many, February 8, 2023
To the surprise of many in the healthcare community, mushrooms and ecstasy will be available by prescription from authorised psychiatrists to treat depression and post-traumatic stress disorder (PTSD) in controlled conditions from 1 July. Much like the approval of Medicinal Cannabis back in 2016, Australia’s medical regulator shock decision has opened the door to alternative mental health treatments following the promising results from international studies investigating the role MDMA and Psilocybin can play in treating mental health conditions.